Abcam plc stock is up 3.99% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
01 Nov 17:45 | 19 Jan, 2024 | 22.50 | 7943 | ||
14 Nov 20:19 | 19 Jan, 2024 | 22.50 | 5641 | ||
16 Nov 19:02 | 16 Feb, 2024 | 22.50 | 30 | ||
21 Nov 14:34 | 20 Sep, 2024 | 22.50 | 206 | ||
21 Nov 20:26 | 20 Dec, 2024 | 20.00 | 0 | ||
21 Nov 20:38 | 20 Dec, 2024 | 20.00 | 0 | ||
21 Nov 20:40 | 20 Dec, 2024 | 20.00 | 0 | ||
21 Nov 20:57 | 16 Jan, 2026 | 22.50 | 136 | ||
21 Nov 20:57 | 17 Jan, 2025 | 20.00 | 0 | ||
21 Nov 20:58 | 17 Jan, 2025 | 20.00 | 0 |
Abcam plc focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of Asia Pacific.